In our results, IL-6 was suppressed in EBF1-overexpressing CCA cells, suggesting that promoter hypermethylation of EBF1 in CCA may be activated by IL-6/STAT3 signaling pathway. This evidence concerns the gene STAT3 and cholangiocarcinoma.